LSV Asset Management reduced its stake in shares of DaVita Inc. (NYSE:DVA - Free Report) by 6.4% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 962,329 shares of the company's stock after selling 66,100 shares during the quarter. LSV Asset Management owned about 1.25% of DaVita worth $147,207,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other institutional investors have also added to or reduced their stakes in the stock. United Capital Financial Advisors LLC raised its holdings in shares of DaVita by 2.6% in the fourth quarter. United Capital Financial Advisors LLC now owns 2,416 shares of the company's stock valued at $361,000 after acquiring an additional 62 shares in the last quarter. Freedom Investment Management Inc. raised its holdings in shares of DaVita by 3.6% in the fourth quarter. Freedom Investment Management Inc. now owns 1,790 shares of the company's stock valued at $268,000 after acquiring an additional 62 shares in the last quarter. Wealth Enhancement Advisory Services LLC raised its holdings in shares of DaVita by 2.0% in the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 3,551 shares of the company's stock valued at $531,000 after acquiring an additional 69 shares in the last quarter. UMB Bank n.a. raised its holdings in shares of DaVita by 65.5% in the first quarter. UMB Bank n.a. now owns 192 shares of the company's stock valued at $29,000 after acquiring an additional 76 shares in the last quarter. Finally, Exchange Traded Concepts LLC raised its holdings in shares of DaVita by 8.9% in the first quarter. Exchange Traded Concepts LLC now owns 970 shares of the company's stock valued at $148,000 after acquiring an additional 79 shares in the last quarter. 90.12% of the stock is owned by hedge funds and other institutional investors.
Insider Buying and Selling
In related news, insider James O. Hearty sold 2,351 shares of the stock in a transaction on Wednesday, July 23rd. The stock was sold at an average price of $150.00, for a total value of $352,650.00. Following the completion of the transaction, the insider directly owned 26,038 shares of the company's stock, valued at approximately $3,905,700. This represents a 8.28% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 2.00% of the company's stock.
DaVita Stock Down 1.4%
Shares of DVA stock traded down $1.93 during trading hours on Friday, reaching $138.44. 686,266 shares of the company's stock were exchanged, compared to its average volume of 707,150. DaVita Inc. has a 1 year low of $131.76 and a 1 year high of $179.60. The stock has a market cap of $10.45 billion, a PE ratio of 13.72, a PEG ratio of 0.96 and a beta of 1.09. The stock's fifty day moving average price is $140.44 and its two-hundred day moving average price is $147.70. The company has a current ratio of 1.25, a quick ratio of 1.20 and a debt-to-equity ratio of 23.18.
DaVita (NYSE:DVA - Get Free Report) last announced its quarterly earnings results on Monday, May 12th. The company reported $2.00 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.75 by $0.25. The company had revenue of $3.22 billion during the quarter, compared to the consensus estimate of $3.22 billion. DaVita had a return on equity of 176.11% and a net margin of 6.63%. DaVita's revenue for the quarter was up 5.0% on a year-over-year basis. During the same period in the previous year, the company posted $2.26 earnings per share. Research analysts predict that DaVita Inc. will post 10.76 EPS for the current year.
Analyst Ratings Changes
Several analysts recently weighed in on the company. Truist Financial decreased their price objective on DaVita from $170.00 to $164.00 and set a "hold" rating for the company in a report on Monday, May 19th. Wall Street Zen upgraded DaVita from a "hold" rating to a "buy" rating in a research note on Friday, April 25th. One research analyst has rated the stock with a sell rating, three have given a hold rating and two have issued a buy rating to the company's stock. According to data from MarketBeat.com, the stock presently has an average rating of "Hold" and a consensus target price of $167.40.
View Our Latest Analysis on DVA
About DaVita
(
Free Report)
DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.
Featured Articles

Before you consider DaVita, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DaVita wasn't on the list.
While DaVita currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.